BiotechTubeBiotechTube
Home/Kamada/Dr. Eyal Rubin
DE

Dr. Eyal Rubin

Senior Vice President, Finance & Treasurer

Kamada

Roles

Senior Vice President, Finance & TreasureratKamada
Senior Vice President, Chief Financial Officer and TreasureratProtalix BioTherapeutics

Therapeutic Areas

Rare DiseasesPulmonaryHematologyInfectious Diseases

Kamada Pipeline

DrugIndicationPhase
Glassia® (IV AAT)Alpha-1 Antitrypsin Deficiency (AATD)Approved
Inhaled AAT (KMA-001)Alpha-1 Antitrypsin Deficiency (AATD)Phase 3
KEDRAB®Rabies Post-Exposure ProphylaxisApproved
Fibrinogen Concentrate (Human)Congenital Fibrinogen DeficiencyPhase 3
Anti-SARS-CoV-2 Plasma (Immunoglobulin)Hospitalized COVID-19Phase 1/2
Anti-RhD Immunoglobulin (IVIg)Immune Thrombocytopenic Purpura (ITP)Pre-clinical
Anti-CD38 AntibodyOncology (Multiple Myeloma)Pre-clinical

Leadership Team at Kamada

AL
Amir London
Chief Executive Officer
GL
Guy Lebowitz
Chief Financial Officer
JB
Joshua Berkman
Chief Business Officer
NB
Nurit Benjamini
Chief Operating Officer
DE
Dr. Eran Schenker
Chief Medical Officer
DD
Dr. Dana Biran-Tal
Vice President, Research & Development
AA
Adi Azaria
Chairman of the Board
C(
Chaime (Chaiko) Orlev
Director
DY
Dr. Yaron Naos
Director
AN
Anat Naschitz
Director
View full Kamada profile